pertuzumab, trastuzumab, and hyaluronidase-zzxf

FDA Drug Profile — Phesgo

pertuzumab, trastuzumab, and hyaluronidase-zzxf is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Phesgo. Available dosage form: injection, solution.

Drug details

Generic Name
pertuzumab, trastuzumab, and hyaluronidase-zzxf
Brand Names
Phesgo
Application Number
BLA761170
Sponsor
Genentech, Inc.
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
PERTUZUMAB, TRASTUZUMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.